This publisher's note corrects the funding in J. Opt. Soc. Am. A36, B110 (2019).JOAOD60740-323210.1364/JOSAA.36.00B110.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1364/JOSAA.396225 | DOI Listing |
The Awards for Distinguished Contributions to Psychology in the Public Interest recognize persons who have advanced psychology as a science and/or profession by a single extraordinary achievement or a lifetime of outstanding contributions in the public interest. Anjhula Mya Singh Bais is the chair of the International Board of Amnesty International, the first psychologist in this role. Dr.
View Article and Find Full Text PDFJ Bone Joint Surg Am
December 2024
Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
Background: The direct anterior approach (DAA) is a popular approach for primary total hip arthroplasty (THA). However, the contemporary outcomes for DAA THA need further elucidation. Therefore, we aimed to describe implant survivorship, complications, and clinical outcomes after DAA THA.
View Article and Find Full Text PDFFront Pharmacol
December 2024
Department of Nephrology, West China Hospital of Sichuan University, Chengdu, China.
Background And Objective: Uremic pruritus is a persistent condition that is difficult to cure in patients with end-stage renal disease who are having regular dialysis. It is highly prevalent, and current therapies have limited effectiveness and can cause significant adverse effects. Several trials have provided evidence that difelikefalin can be an effective treatment for uremic pruritus, with few side responses.
View Article and Find Full Text PDFNeurochirurgie
December 2024
Institute of Functional Genomics, Montpellier University, CNRS, INSERM, Montpellier, France; French Brain Tumor DataBase (Recensement national histologique des Tumeurs Primitives du SNC), CHU/ICM Montpellier, Montpellier, France; Department of Medical Oncology, Institut régional du Cancer de Montpellier (ICM), University of Montpellier, Montpellier, France.
Background: The recent advent of anti-IDH therapies and changes in the WHO classification of gliomas implies estimating the number of patients who could benefit (or not) from anti-IDH treatment. As published data on the current incidence of different subtypes of IDH-mutant gliomas (based on the latest histomolecular WHO classification) are lacking in many countries. The present analysis aims to review the main factors impacting the incidence of gliomas and lower-grade gliomas and to estimate the incidence and prevalence of IDH-mutant gliomas in France.
View Article and Find Full Text PDFJ Orthop Surg Res
December 2024
Department of Orthopaedic Surgery, Jikei University School of Medicine, 3-25-8, Nishi- Shimbashi, Minato-ku, Tokyo, 105-8461, Japan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!